11 studies found for: "Charcot-Marie-Tooth disease type 1A"
|1||Not yet recruiting||
Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and Biomarkers
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Driving Ability in Patients With CMT 1A
Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot−Marie−Tooth Neuropathy Type 1A (CMT1A)
Correlation Between Clinical and Electrophysiological Phenotypes in a Population of Patients With Neuropathy Charcot-Marie-Tooth Disease Type 1A
Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A
High Dose Ascorbic Acid Treatment of CMT1A
Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
|9||Not yet recruiting||
Ulipristal Acetate In Disease Charcot-Marie-Tooth Type of 1A
Ascorbic Acid Treatment in CMT1A Trial (AATIC)
SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study
† Study has passed its completion date and status has not been verified in more than two years.